Osiris Therapeutics, Inc. • 7015 Albert Einstein Drive • Columbia, MD • 21046 • p(443) 545-1800 osiris@osiris.com Legal Notice
Corporate Info Osiris Advantage Management Directors Benefits Equal Opportunity Prochymal Chondrogen Product Pipeline Stem Cell Source Our Process Key Partnerships
Osiris Therapeutics Announces Second Quarter 2010 Financial Results Conference Call (07/29/10)

Prochymal New Drug Submission Granted Priority Review by Health Canada (07/21/10)

Osiris Therapeutics Reports First Quarter 2010 Financial Results (05/07/10)

Osiris Resumes Enrollment in Stem Cell Trial for Crohn’s Disease Following Positive Interim Analysis (05/05/10)